Tampa, FL – Dr. Robert Goldberg, Healthesystems’ chief medical officer, will host The California DWC Formulary: An Introduction, as part of the Western Occupational & Environmental Medical Association’s (WOEMA) continuing medical education webinar series.
The 2017 implementation of the California DWC drug formulary will impact care for hundreds of thousands of injured workers. Thus great attention has been turned to the current draft regulations, which add an important layer of clinical context to guide drug therapy. The formulary is notably linked to the California Medical Treatment Utilization Schedule (MTUS) and driven by the American College of Occupational and Environmental Medicine (ACOEM) treatment guidelines. The DWC adoption of a closed drug formulary grounded in such high-quality evidence-based guidelines will place drug therapy decisions within the context of the injury or condition being treated, rather than the availability of the medication alone.
Dr. Goldberg will speak to the development of the DWC formulary, its potential clinical and cost benefits, provide insight into its functionality and application, and discuss important considerations for implementation.
Participants in the webinar will be able to:
- Summarize the development of the formulary from evidence-based occupational medical treatment guidelines
- Explain the potential clinical and cost benefits of a closed drug formulary supported by evidence-based guidelines
- Describe the considerations that are important to the successful implementation and adoption of a state-based formulary
- Describe the functionality of the formulary and the supporting tools to make prescribing decisions for injured workers
The webinar airs December 21, 2016 at 12:00 pm PT.
Click here to register: WOEMA: The California DWC Formulary: An Introduction
Healthesystems is a WorkCompWire ad partner.
This is not a paid placement.